[Phase III study for local or locally advanced prostate cancer : Randomized, double-blind, placebo-controlled phase 3 study of apalutamide in patients with local high-risk prostate cancer or locally advanced prostate cancer receiving primary radiotherapy (ATLAS) - study AP 90/15 of the AUO]

Urologe A. 2017 Feb;56(2):243-244. doi: 10.1007/s00120-017-0329-0.
[Article in German]
No abstract available

Publication types

  • Clinical Trial, Phase III
  • Randomized Controlled Trial

MeSH terms

  • Androgen Receptor Antagonists / administration & dosage
  • Chemoradiotherapy / methods*
  • Double-Blind Method
  • Germany
  • Humans
  • Male
  • Neoplasm Recurrence, Local / pathology*
  • Neoplasm Recurrence, Local / prevention & control*
  • Placebo Effect
  • Prostatic Neoplasms / pathology*
  • Prostatic Neoplasms / therapy*
  • Risk Factors
  • Thiohydantoins / administration & dosage*
  • Treatment Outcome

Substances

  • Androgen Receptor Antagonists
  • Thiohydantoins
  • apalutamide